Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD

Bacteria are isolated in more than 50% of exacerbations of chronic bronchitis (CB) and chronic obstructive pulmonary disease (COPD). The most prevalent respiratory pathogens include Gram-positive (Streptococcus pneumoniae) and Gram-negative (Haemophilus influenzae, Moraxella catarrhalis) microorgani...

Descripción completa

Detalles Bibliográficos
Autor principal: Miravitlles, Marc
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695197/
https://www.ncbi.nlm.nih.gov/pubmed/18229559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695197/
https://www.ncbi.nlm.nih.gov/pubmed/18229559

Ejemplares similares